Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David J. Press
Community Clinical Practice Patterns and Mortality in Patients With Intermediate Oncotype DX Recurrence Scores: Who Benefits From Chemotherapy?
Cancer
Cancer Research
Oncology
Related publications
Treatment Decisions in Estrogen Receptor-Positive Early Breast Cancer Patients With Intermediate Oncotype DX Recurrence Score Results
SpringerPlus
Multidisciplinary
Oncotype Dx Recurrence Score Among BRCA1/2 Germline Mutation Carriers With Hormone Receptors Positive Breast Cancer
International Journal of Cancer
Cancer Research
Oncology
Oncotype DX Breast Cancer Recurrence Score Resists Inter-Assay Reproducibility With RT2-Profiler Multiplex RT-PCR
Scientific Reports
Multidisciplinary
Examination of the Biomark Assay as an Alternative to Oncotype DX for Defining Chemotherapy Benefit
Oncology Letters
Cancer Research
Oncology
The Impact of Oncotype DX® Recurrence Score of Paraffin-Embedded Core Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in Women With Breast Cancer
Breast Disease
Medicine
Cancer Research
Oncology
The ZNF217 Biomarker Predicts Low- And High-Risk Oncotype DX® Recurrence Score in ER-Positive Invasive Breast Cancers
Frontiers in Pharmacology
Pharmacology
Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients With Colorectal Liver Metastases
Annals of Surgical Oncology
Oncology
Surgery
Effect of Oncotype DX Colon Cancer Test Results on Treatment Recommendations in Patients With Stage II Colon Cancer: Preliminary Results.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Survival Prediction in Patients With Resectable Colorectal Liver Metastases: Clinical Risk Scores and Tumor Response to Chemotherapy
Oncology Letters
Cancer Research
Oncology
